SCNI (Scinai Immunotherapeutics) Forvard P/E multiplikatori

Scinai (SCNI) kompaniyasining korporativ logotipi

Bioreaktor avtomatizatsiyasi va antitelalarni to‘ldirishni robotlashtirish xodimlar xatolarini minimallashtirib, nanotana antitelalari patentlari va FDA ning yuqori kirish to‘siqlari orqali nishani himoya qilish uchun asos yaratadi. Scinai Immunotherapeutics (SCNI) kompaniyasining oldingi P/E baholanishi ushbu tendentsiyani aniq tasdiqlaydi, bunda oxirgi qiymat 0.00 deb qayd etilgan. Noyob antitelalarning ishlab chiqilishi umumiy manzarani yakunlab, infeksiyalarning oldini olish sektorida uzoq muddatli yetakchilikni ta'minlaydi.

Prognoz qilingan narxning foydaga nisbati: Scinai Immunotherapeutics Ltd. (SCNI) 21.02.2024 - 17.11.2026 uchun

Scinai Immunotherapeutics kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning jamlanma tahliliyoti:scinai.com
Scinai Immunotherapeutics tovar namunasi

Scinai Immunotherapeutics (SCNI) yallig'lanish kasalliklarini davolash uchun nanoantitelalarni etik tarzda ishlab chiqayotgani sababli Isroilda yuqori ilmiy nufuzga ega. Investor kompaniyaning forward P/E koeffitsiyentini tahlil qilish orqali joriy aktiv qiymatini bir yildan keyin kutilayotgan daromadlar bilan nisbatda baholaydi, bu esa koeffitsiyent dinamikasini oltin va obligatsiya bozorlari bilan solishtirish orqali aktivlarning haddan tashqari qimmat baholanganini yoki talabning pasayishini aniqlash imkonini beradi.

Scinai Immunotherapeutics (SCNI) raqobatchilari

Prognoz qilingan narxning foydaga nisbati ARGX (Argenx)|BNTX (BioNTech Group) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori ABVX (Abivax SA)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati admabiologics.com (ADMA)|PTGX - Kelajakdagi narxning foydaga nisbati|Immunovant Inc (IMVT) - Prognoz qilingan narxning foydaga nisbati|Kiniksa Corp (KNSA) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Grifols, S.A.|Prognoz qilingan narxning foydaga nisbati ADPT|Forvard P/E multiplikatori celldex.com|Kelajakdagi narxning foydaga nisbati Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Narxning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori VERA (veratx.com)|Dianthus Pharma (DNTH) - Prognoz qilingan narx-foyda nisbati|PHVS - Kelajakdagi narxning foydaga nisbati|ABCL - Forvard P/E multiplikatori|Tourmaline (TRML) - Kelajakdagi narxning foydaga nisbati|Precigen - Kelajakdagi narx-foyda multiplikatori|PHAR (Pharming Group NV) - Forvard P/E multiplikatori|Forvard P/E multiplikatori Nektar Therapeutics|Kelajakdagi narxning foydaga nisbati Upstream Bio Inc (UPB)|Forvard P/E multiplikatori zenasbio.com (ZBIO)|Kelajakdagi narxning foydaga nisbati Immunome Corp IMNM|Forvard P/E multiplikatori Gossamer Bio Inc GOSS|KALV - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori SEPN (Septerna Pharma)|PVLA (Pieris Pharmaceuticals) - Prognoz qilingan narxning foydaga nisbati|Savara Inc. - Kelajakdagi narx-foyda multiplikatori|RIGL (Rigel Pharmaceuticals, Inc.) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati ANAB|Forvard P/E multiplikatori ATXS|ENGN - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori RAPT (rapt.com)|Kapitalizatsiyaning kelajakdagi foydaga nisbati JBIO (Aerovate)|Aclaris Therapeutics, Inc - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Kyverna Therapeutics Inc.|TLSA: Forvard P/E multiplikatori|CABA - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|VTYX (ventyxbio.com) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Theratechnologies Inc. THTX|Prognoz qilingan narxning foydaga nisbati AVTX (avalotx.com)|Prognoz qilingan narxning foydaga nisbati Eledon Pharmaceuticals, Inc. ELDN|Kelajakdagi narxning foydaga nisbati Agenus, Inc AGEN|Climb Bio Inc - Kelajakdagi narxning foydaga nisbati|Zura Bio Limited - Forvard P/E multiplikatori|Kapitalizatsiyaning prognoz qilingan foydaga nisbati aTyr Pharma, Inc. ATYR|ADAG: Forvard P/E multiplikatori|Narxning kutilayotgan foydaga nisbati IMA (ImageneBio)|Prognoz qilingan narxning foydaga nisbati STTK|EQ: Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Connect Pharma (CNTB)|Forvard P/E multiplikatori Immunic Therapeutics (IMUX)|Forvard P/E multiplikatori ATRA (Atara Biotherapeutics)|Kelajakdagi narx-foyda multiplikatori IFRX|XFOR (X4 Pharma) - Prognoz qilingan narx-foyda nisbati|Kelajakdagi narx-foyda multiplikatori ACET (adicetbio.com)|CELU: Forvard P/E multiplikatori|inmunebio.com (INMB) - Forvard P/E multiplikatori|BRNS (Barinthus Biotherapeutics PLC) - Forvard P/E multiplikatori|KZR: Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati SAB Biotherapeutics, Inc. (SABS)|AKTX (Akari Therapeutics plc) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Enlivex Therapeutics Ltd ENLV|QTTB - Prognoz qilingan narxning foydaga nisbati|geovax.com - Forvard P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori EDSA (Edesa Biotech Inc)|IBIO: Forvard P/E multiplikatori|Carisma Tx (CARM) - Forvard P/E multiplikatori|XTLB (XTL Biopharmaceuticals) - Forvard P/E multiplikatori|BOLT: Kelajakdagi narx-foyda multiplikatori|Prognoz qilingan narxning foydaga nisbati HCWB (HCW Biologics, Inc.)|Forvard P/E multiplikatori Aptevo (APVO)|Forvard P/E multiplikatori AIM (aimimmuno.com)|Forvard P/E multiplikatori Aditxt Corp ADTX|GRI: Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori XRTX (xortx.com)|Vyome Holdings Inc. (HIND) - Kelajakdagi narxning foydaga nisbati|Revelation Bio (REVB) - Forvard P/E multiplikatori|INDP (Indaptus Corp) - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati CalciMedica, Inc. CALI|Kelajakdagi narxning foydaga nisbati Affimed NV (AFMD)|Forvard P/E multiplikatori Allakos Inc (ALLK)|Kelajakdagi narxning foydaga nisbati hookipapharma.com HOOK|Forvard P/E multiplikatori IGM Biosciences, Inc. IGMS|iTeos Pharma - Forvard P/E multiplikatori|OCEA - Forvard P/E multiplikatori|TCBP: Forvard P/E multiplikatori|Third Harmonic Bio - Kelajakdagi narx-foyda multiplikatori